Sfoglia per Rivista CANCER DISCOVERY
Evading the STING: LKB1 loss leads to STING silencing and immune escape in KRAS-mutant lung cancers
2019 Della Corte, C. M.; Byers, L. A.
HER2 Signaling and Resistance to the Anti-EGFR Monoclonal Antibody Cetuximab: A Further Step toward Personalized Medicine for Patients with Colorectal Cancer.
2011 Ciardiello, Fortunato; Normanno, N.
Induction of apobec3 exacerbates dna replication stress and chromosomal instability in early breast and lung cancer evolution
2021 Venkatesan, S.; Angelova, M.; Puttick, C.; Zhai, H.; Caswell, D. R.; Lu, W. -T.; Dietzen, M.; Galanos, P.; Evangelou, K.; Bellelli, R.; Lim, E. L.; Watkins, T. B. K.; Rowan, A.; Teixeira, V. H.; Zhao, Y.; Chen, H.; Ngo, B.; Zalmas, L. -P.; Al Bakir, M.; Hobor, S.; Gronroos, E.; Pennycuick, A.; Nigro, E.; Campbell, B. B.; Brown, W. L.; Akarca, A. U.; Marafioti, T.; Mary, Y. W.; Howell, M.; Boulton, S. J.; Bertoli, C.; Fenton, T. R.; De Bruin, R. A. M.; Maya-Mendoza, A.; Santoni-Rugiu, E.; Hynds, R. E.; Gorgoulis, V. G.; Jamal-Hanjani, M.; Mcgranahan, N.; Harris, R. S.; Janes, S. M.; Bartkova, J.; Bakhoum, S. F.; Bartek, J.; Kanu, N.; Swanton, C.
Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer
2019 Sen, T.; Rodriguez, B. L.; Chen, L.; Della Corte, C. M.; Morikawa, N.; Fujimoto, J.; Cristea, S.; Nguyen, T.; Diao, L.; Li, L.; Fan, Y.; Yang, Y.; Wang, J.; Glisson, B. S.; Wistuba, I. I.; Sage, J.; Heymach, J. V.; Gibbons, D. L.; Byers, L. A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Evading the STING: LKB1 loss leads to STING silencing and immune escape in KRAS-mutant lung cancers | 1-gen-2019 | Della Corte, C. M.; Byers, L. A. | |
HER2 Signaling and Resistance to the Anti-EGFR Monoclonal Antibody Cetuximab: A Further Step toward Personalized Medicine for Patients with Colorectal Cancer. | 1-gen-2011 | Ciardiello, Fortunato; Normanno, N. | |
Induction of apobec3 exacerbates dna replication stress and chromosomal instability in early breast and lung cancer evolution | 1-gen-2021 | Venkatesan, S.; Angelova, M.; Puttick, C.; Zhai, H.; Caswell, D. R.; Lu, W. -T.; Dietzen, M.; Galanos, P.; Evangelou, K.; Bellelli, R.; Lim, E. L.; Watkins, T. B. K.; Rowan, A.; Teixeira, V. H.; Zhao, Y.; Chen, H.; Ngo, B.; Zalmas, L. -P.; Al Bakir, M.; Hobor, S.; Gronroos, E.; Pennycuick, A.; Nigro, E.; Campbell, B. B.; Brown, W. L.; Akarca, A. U.; Marafioti, T.; Mary, Y. W.; Howell, M.; Boulton, S. J.; Bertoli, C.; Fenton, T. R.; De Bruin, R. A. M.; Maya-Mendoza, A.; Santoni-Rugiu, E.; Hynds, R. E.; Gorgoulis, V. G.; Jamal-Hanjani, M.; Mcgranahan, N.; Harris, R. S.; Janes, S. M.; Bartkova, J.; Bakhoum, S. F.; Bartek, J.; Kanu, N.; Swanton, C. | |
Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer | 1-gen-2019 | Sen, T.; Rodriguez, B. L.; Chen, L.; Della Corte, C. M.; Morikawa, N.; Fujimoto, J.; Cristea, S.; Nguyen, T.; Diao, L.; Li, L.; Fan, Y.; Yang, Y.; Wang, J.; Glisson, B. S.; Wistuba, I. I.; Sage, J.; Heymach, J. V.; Gibbons, D. L.; Byers, L. A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile